Medpharma secures undisclosed investment from Sahara Impact Ventures.

Ghanaian healthtech startup Medpharma has raised an undisclosed funding round from Sahara Impact Ventures.

What problem is MedPharma solving? 

Founded by Stephen Yaw Asamoah and Richard Appiah Otoo in 2019, MedPharma is digitising healthcare delivery by aggregating providers, pharmacies, and medical facilities into a single connected platform. Its model tackles one of the continent’s most persistent challenges: fragmented access to quality and affordable healthcare.

Through the MedPharma app, patients can consult doctors virtually, order medications in real time, and access nearby facilities without friction. Its e-consultation service, WeCare, enables users to book appointments via video or chat, while an integrated system allows secure storage of medical records and remote monitoring of health progress. Medication delivery is built into the service, offering convenience and cost savings across the healthcare value chain.

The company’s technology reduces inefficiencies between patients, providers, and suppliers—cutting waiting times, improving transparency, and bringing down the cost of care. MedPharma also operates a secure, encrypted back-office counselling system to maintain patient confidentiality and data integrity.

Who is the backer betting on the jockey?

Sahara Impact Ventures is a female-led investment advisory and venture capital fund management firm based in Accra, Ghana. Its inaugural vehicle, Sahara Impact Ventures Fund I, is targeting a corpus of USD 30 million to invest in high-growth businesses from pre-seed to Series A that operate at the intersection of gender and climate in West Africa. The fund writes cheques of up to USD 400,000 in equity and quasi-equity deals, backing enterprises within sustainable food systems, clean energy, and access to essential services such as healthcare, finance, and education. Beyond capital, Sahara Impact Ventures provides tailored technical assistance to strengthen investment readiness and drive long-term value creation across its portfolio.